Investor Relations

Life science company focused on
solving Duchenne muscular dystrophy

Solid Biosciences is a life science company focused solely on finding meaningful therapies for Duchenne muscular dystrophy (Duchenne). Founded by those touched by the disease, Solid is a center of excellence for Duchenne, bringing together experts in science, technology and care to drive forward a portfolio of candidates that have life-changing potential.

Stock Information

NASDAQ SLDB

Copyright West LLC.
Minimum 15 minutes delayed.
Press Releases